Forward Science™ is a privately held biotechnology company based in Houston, Texas. The medical device company was founded with the goal of advancing oral healthcare through early discovery (OralID), diagnostics (CytID, PathID, hpvID, phID), and treatment options (SalivaMAX, SalivaCAINE).
OralID, Forward Science’s flagship product, is an award winning oral cancer screening device that allows clinicians to Shine Light. Change Lives.™ by identifying abnormalities that may not be seen under traditional white light examinations. Forward Science quickly expanded its product portfolio in efforts to provide clinicians with a complete program to battle the rising trends of oral cancer. With the launch of the ID For Life™ Program, Forward Science has evolved into the industry leader for oral oncology. The ID For Life™ Program includes the following in an effort to change the trends for oral cancer: screening device (OralID), diagnostic tests (CytID, PathID, hpvID, phID), and treatment options (SalivaMAX, SalivaCAINE). SalivaMAX is an FDA Cleared prescription strength rinse for all ranges of xerostomia; whereas, SalivaCAINE is used to relieve the pain. Together, SalivaMAX and SalivaCAINE are a true solution for the common side effects cancer patients experience on a regular basis.